CervoMed Inc. - CRVO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$9.76M
QoQ value delta ($000)
-$7.637M (-43.9%)
Implied price effect (QoQ)
-41.8%
Shares
Total shares
2,124,554
QoQ shares delta
-79,414 (-3.6%)
Total shares held by funds (by quarter)

Market chart (CRVO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 36 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
MORGAN STANLEY 2,915 739,892 0.0%
VANGUARD GROUP INC 2,804 354,950 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 1,245 316,202 0.0%
MILLENNIUM MANAGEMENT LLC 823 208,908 0.0%
GEODE CAPITAL MANAGEMENT, LLC 293 74,371 0.0%
RENAISSANCE TECHNOLOGIES LLC 251 63,904 0.0%
BlackRock, Inc. 203 51,660 0.0%
XTX Topco Ltd 151 38,487 0.0%
CITIZENS FINANCIAL GROUP INC/RI 147 37,477 0.0%
VANGUARD FIDUCIARY TRUST CO 142 36,151 0.0%
NORTHERN TRUST CORP 118 30,044 0.0%
Cetera Investment Advisers 107 27,337 0.0%
Savvy Advisors, Inc. 102 25,922 0.0%
STATE STREET CORP 80 20,527 0.0%
JANE STREET GROUP, LLC 71 18,246 0.0%
Russell Investments Group, Ltd. 63 16,090 0.0%
Byrne Asset Management LLC 57 14,700 0.03%
HighTower Advisors, LLC 44 11,265 0.0%
FMR LLC 43 11,040 0.0%
THOMPSON DAVIS & CO., INC. 39 10,000 0.03%
UBS Group AG 20 5,239 0.0%
NFSG Corp 11 3,000 0.0%
Vanguard Global Advisers, LLC 10 2,597 0.0%
Tower Research Capital LLC (TRC) 8 2,178 0.0%
Federation des caisses Desjardins du Quebec 6 1,700 0.0%